137 related articles for article (PubMed ID: 25243946)
1. PET/CT imaging of squamoid eccrine ductal carcinoma.
Wang B; Jarell AD; Bingham JL; Bonavia GH
Clin Nucl Med; 2015 Apr; 40(4):322-4. PubMed ID: 25243946
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT in diagnosing and staging cutaneous eccrine adenocarcinoma.
Xing XL; Gao S; Li YJ
Clin Nucl Med; 2012 Mar; 37(3):284-6. PubMed ID: 22310258
[No Abstract] [Full Text] [Related]
3. Apocrine sweat gland carcinoma: initial evaluation, staging, and response monitoring using 18F-FDG PET/CT.
Singh H; Sharma P; Suman Kc S; Bal C; Malhotra A; Julka PK; Kumar R
Clin Nucl Med; 2013 May; 38(5):e223-5. PubMed ID: 23377411
[TBL] [Abstract][Full Text] [Related]
4. FDG PET/CT in malignant eccrine porocarcinoma arising in a pre-existing poroma.
Golemi A; Hanspeter E; Brugger E; Ruiu A; Farsad M
Clin Nucl Med; 2014 May; 39(5):456-8. PubMed ID: 23917787
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of recurrent squamoid eccrine ductal carcinoma of the scalp.
Kim JW; Jeon MK; Kang SJ; Sun H
J Craniofac Surg; 2012 Jul; 23(4):e276-8. PubMed ID: 22801148
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT in Malignant Eccrine Spiradenoma.
Sanchez Petitto G; Sarwari NM; Jain P; Swaby M; Bhattacharjee M
Clin Nucl Med; 2017 Feb; 42(2):125-126. PubMed ID: 28005641
[TBL] [Abstract][Full Text] [Related]
7. Metastatic eccrine porocarcinoma detected on FDG PET/CT.
Li SH; Chen MT; Chen YJ; Wang SL; Chang-Yu W
Clin Nucl Med; 2007 Sep; 32(9):743-5. PubMed ID: 17710036
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
9. Squamoid eccrine ductal carcinoma.
Saraiva MI; Vieira MA; Portocarrero LK; Fraga RC; Kakizaki P; Valente NY
An Bras Dermatol; 2016; 91(6):799-802. PubMed ID: 28099603
[TBL] [Abstract][Full Text] [Related]
10. F-18 FDG PET/CT imaging of a hidradenocarcinoma of head and neck.
Surasi DS; Lam S; Subramaniam RM
Clin Nucl Med; 2011 Oct; 36(10):945-7. PubMed ID: 21892057
[No Abstract] [Full Text] [Related]
11. Prone 18F-FDG PET/CT changes diagnostic and surgical intervention in a breast cancer patient: some considerations about PET/CT imaging acquisition protocol.
Canevari C; Gallivanone F; Zuber V; Marassi A; Losio C; Gianolli L; Gilardi MC; Castiglioni I
Clin Imaging; 2015; 39(3):506-9. PubMed ID: 25620014
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT of Liver Lymphoepithelioma-like Carcinoma.
Lee SD; Chiu YL; Wu CS; Peng NJ
Clin Nucl Med; 2015 Sep; 40(9):732-3. PubMed ID: 26018687
[TBL] [Abstract][Full Text] [Related]
13. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
14. A rare case of metastatic clear cell carcinoma of the Müllerian system originating from the peritoneum assessed by 18F-FDG PET/CT.
Treglia G; Barizzi J; Paone G; Ceriani L; Bongiovanni M; Giovanella L
Clin Nucl Med; 2015 Jan; 40(1):e58-60. PubMed ID: 24561679
[TBL] [Abstract][Full Text] [Related]
15. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
16. Utility of contrast-enhanced FDG-PET/CT in the clinical management of pancreatic cancer: impact on diagnosis, staging, evaluation of treatment response, and detection of recurrence.
Asagi A; Ohta K; Nasu J; Tanada M; Nadano S; Nishimura R; Teramoto N; Yamamoto K; Inoue T; Iguchi H
Pancreas; 2013 Jan; 42(1):11-9. PubMed ID: 22699206
[TBL] [Abstract][Full Text] [Related]
17. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
18. Recurrent ureteric transitional cell carcinoma presenting as an isolated brain metastasis: incidental detection with 18F-FDG PET/CT.
Sharma P; Chatterjee P
Clin Nucl Med; 2015 Mar; 40(3):273-4. PubMed ID: 25275417
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
20. Myofibroma of the Left Supraspinous Muscle on 18F-FDG PET/CT.
Fang N; Wang YL; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2016 Apr; 41(4):317-8. PubMed ID: 26402126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
